Abstract
With more than 5 million cases and 333,212 deaths, COVID-19 (or SARS-CoV-2) continues to spread. General symptoms of this disease are similar to that of many other viral respiratory diseases, including fever, cough, dyspnea, and fatigue, with a chance of progression to more severe complications. However, the virus does not affect all people equally, and cases with comorbidities such as malignancies, cardiovascular diseases, respiratory diseases, and kidney diseases are at higher risk of develo** severe events, including requiring intensive ventilation, intensive care unit (ICU) admission, and death. Patients with cancer are more likely to be infected with COVID-19, which is possibly due to their immunological dysfunction or frequent clinic visits. Also, there is a higher chance that these patients experience severe events because of the medication they receive. In this chapter, we will review the main clinical manifestations of COVID-19 in patients with cancer. Recommendations and challenges for managing resources, organizing cancer centers, treatment of COVID-19-infected cancer patients, and performing cancer research during this pandemic will also be discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ahanchian H, Moazzen N, Faroughi MSD, Khalighi N, Khoshkhui M, Aelami MH, Haghi NSM, Rezaei N (2020) COVID-19 in a Child with Primary Specific Antibody Deficiency
Ahmadi M, Saffarzadeh N, Habibi MA, Hajiesmaeili F, Rezaei N (2020) Colon cancer and SARS-CoV-2: impact of ACE2 expression in susceptibility to COVID-19. bioRxiv
Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, Wolff R, Nuhad IK, Chua MLK, Hotte SJ, Meyers BM, Elfiki T, Curigliano G, Eng C, Grothey A, **e C (2020) A practical approach to the Management of Cancer Patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncologist 25. https://doi.org/10.1634/theoncologist.2020-0213
Alpert A, Jacobson M (2019) Impact of oncology drug shortages on chemotherapy treatment. Clin Pharmacol Ther 106(2):415–421. https://doi.org/10.1002/cpt.1390
American Society of Clinical Oncology (2020) ASCO Coronavirus Resources. https://www.asco.org/asco-coronavirus-information. Accessed 15 Apr 2020
Arjeyni Y, Goudarzi H, Eslami G, Faghihloo E (2017) Viral respiratory infections in patients with Cancer. Int J Cancer Manag 10(2):e8084. https://doi.org/10.5812/ijcp.8084
Babaha F, Rezaei N (2020) Primary immunodeficiency diseases in COVID-19 pandemic: a predisposing or protective factor? Am J Med Sci. https://doi.org/10.1016/j.amjms.2020.07.027
Bahrami A, Vafapour M, Moazzami B, Rezaei N (2020) Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran. J Paediatr Child Health. https://doi.org/10.1111/jpc.15048
Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G, Levine E, Maker A, Mamounas E, McGuire K, Merchant N, Shibata D, Sohn V, Solorzano C, Turaga K, White R, Yang A, Yoon S, Society of Surgical O (2020) Management of cancer surgery cases during the COVID-19 pandemic: considerations. Ann Surg Oncol. https://doi.org/10.1245/s10434-020-08461-2
Basiri A, Heidari A, Nadi MF, Fallahy MTP, Nezamabadi SS, Sedighi M, Saghazadeh A, Rezaei N (2020a) Microfluidic devices for detection of RNA viruses. Rev Med Virol n/a (n/a):e2154. https://doi.org/10.1002/rmv.2154
Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N (2020b) Regenerative medicine in COVID-19 treatment: real opportunities and range of promises. Stem Cell Rev Rep:1–13. https://doi.org/10.1007/s12015-020-09994-5
Battershill PM (2006) Influenza pandemic planning for cancer patients. Curr Oncol 13(4):119–120
Bitar N, Kattan J, Kourie HR, Mukherji D, Saghir NE (2020) The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic. Future Oncol 16:615. https://doi.org/10.2217/fon-2020-0252
Bitterman R, Eliakim-Raz N, Vinograd I, Zalmanovici Trestioreanu A, Leibovici L, Paul M (2018) Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst Rev 2:CD008983. https://doi.org/10.1002/14651858.CD008983.pub3
Burki TK (2020) Cancer care in the time of COVID-19. Lancet Oncol 21:628. https://doi.org/10.1016/S1470-2045(20)30201-1
Cao Y, Liu X, **ong L, Cai K (2020) Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Med Virol 92:1449. https://doi.org/10.1002/jmv.25822
Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di Palma M (2010) Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18(4):433–437. https://doi.org/10.1007/s00520-009-0681-8
Casanova M, Pagani Bagliacca E, Silva M, Patriarca C, Veneroni L, Clerici CA, Spreafico F, Luksch R, Terenziani M, Meazza C, Podda M, Biassoni V, Schiavello E, Chiaravalli S, Puma N, Bergamaschi L, Gattuso G, Sironi G, Massimino M, Ferrari A (2020) How young patients with cancer perceive the Covid-19 (coronavirus) epidemic in Milan, Italy: is there room for other fears? Pediatr Blood Cancer e28318. https://doi.org/10.1002/pbc.28318
Centers for Disease Control and Prevention (2020) Ending Home Isolation for Immunocompromised Persons with COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/ending-isolation.html. Accessed 17 Apr 2020
Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ, Champlin RE, Aguilera EA, Tarrand JJ, Raad II (2006) Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 85(5):278–287. https://doi.org/10.1097/01.md.0000232560.22098.4e
Chen W, Su XY, Wang VJ, Wang EC, Xu R, Zhong S, Sun G, **a J (2020) Novel coronavirus international public health emergency: guidance on radiation oncology facility operation. Adv Radiat Oncol 5:560. https://doi.org/10.1016/j.adro.2020.03.008
Chen YM, Perng RP, Chu H, Tsai CM, Whang-Peng J (2004) Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms. Lung Cancer 45(1):39–43. https://doi.org/10.1016/j.lungcan.2004.01.002
Cinar P, Kubal T, Freifeld A, Mishra A, Shulman L, Bachman J, Fonseca R, Uronis H, Klemanski D, Slusser K, Lunning M, Liu C (2020) Safety at the time of the COVID-19 pandemic: how to keep our oncology patients and healthcare workers safe. J Natl Compr Cancer Netw 18:1–6. https://doi.org/10.6004/jnccn.2020.7572
Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, Kritas SK (2020) Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 34(2). https://doi.org/10.23812/CONTI-E
Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T (2020) Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol 31:553. https://doi.org/10.1016/j.annonc.2020.03.286
Darbeheshti F, Rezaei N (2020) Genetic predisposition models to COVID-19 infection. Med Hypotheses 142:109818. https://doi.org/10.1016/j.mehy.2020.109818
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (2020) Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics:e20200702. https://doi.org/10.1542/peds.2020-0702
Eccles R (2005) Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 5(11):718–725. https://doi.org/10.1016/S1473-3099(05)70270-X
European Medicines Agency (2020) Guidance on the management of clinical trials during the COVID-19 (Coronavirus) pandemic. https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/guidanceclinicaltrials_covid19_en.pdf. Accessed 18 Apr 2020
Extance A (2020) Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease? BMJ 368:m1174. https://doi.org/10.1136/bmj.m1174
Farhadi S, Ovchinnikov R (2018) The relationship between nutrition and infectious diseases: a review. Biomed Biotechnol Res J (BBRJ) 2(3):168–172. https://doi.org/10.4103/bbrj.bbrj_69_18
Fathi N, Rezaei N (2020) Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int 44(9):1792–1797. https://doi.org/10.1002/cbin.11403
Fisher BT, Danziger-Isakov L, Sweet LR, Munoz FM, Maron G, Tuomanen E, Murray A, Englund JA, Dulek D, Halasa N, Green M, Michaels MG, Madan RP, Herold BC, Steinbach WJ (2018) A Multicenter consortium to define the epidemiology and outcomes of inpatient respiratory viral infections in pediatric hematopoietic stem cell transplant recipients. J Pediatric Infect Dis Soc 7(4):275–282. https://doi.org/10.1093/jpids/pix051
Ganatra S, Hammond SP, Nohria A (2020) The novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer. JACC CardioOncol 2:350. https://doi.org/10.1016/j.jaccao.2020.03.001
Gavillet M, Carr Klappert J, Spertini O, Blum S (2020) Acute leukemia in the time of COVID-19. Leuk Res 92:106353. https://doi.org/10.1016/j.leukres.2020.106353
Hakim H, Dallas R, Zhou Y, Pei D, Cheng C, Flynn PM, Pui CH, Jeha S (2016) Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia. Cancer 122(5):798–805. https://doi.org/10.1002/cncr.29833
Hanaei S, Rezaei N (2020) COVID-19: develo** from an outbreak to a pandemic. Arch Med Res 51:582. https://doi.org/10.1016/j.arcmed.2020.04.021
Handu D, Moloney L, Rozga M, Cheng F (2020) Malnutrition care during the COVID-19 pandemic: considerations for registered dietitian nutritionists evidence analysis center. J Acad Nutr Diet. https://doi.org/10.1016/j.jand.2020.05.012
Hanna TP, Evans GA, Booth CM (2020) Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol 17:268. https://doi.org/10.1038/s41571-020-0362-6
Hijano DR, Maron G, Hayden RT (2018) Respiratory viral infections in patients with cancer or undergoing hematopoietic cell transplant. Front Microbiol 9:3097. https://doi.org/10.3389/fmicb.2018.03097
Hill A, Kiss N, Hodgson B, Crowe TC, Walsh AD (2011) Associations between nutritional status, weight loss, radiotherapy treatment toxicity and treatment outcomes in gastrointestinal cancer patients. Clin Nutr 30(1):92–98. https://doi.org/10.1016/j.clnu.2010.07.015
Jabbari P, Jabbari F, Ebrahimi S, Rezaei N (2020) COVID-19: a chimera of two pandemics. Disaster Med Public Health Prep:1–2. https://doi.org/10.1017/dmp.2020.223
Jabbari P, Rezaei N (2020) With risk of reinfection, is COVID-19 Here to stay? Disaster Med Public Health Prep:1. https://doi.org/10.1017/dmp.2020.274
Jager-Wittenaar H, Dijkstra PU, Vissink A, van der Laan BF, van Oort RP, Roodenburg JL (2011) Malnutrition and quality of life in patients treated for oral or oropharyngeal cancer. Head Neck 33(4):490–496. https://doi.org/10.1002/hed.21473
Jahanshahlu L, Rezaei N (2020a) Central nervous system involvement in COVID-19. Arch Med Res 51:721. https://doi.org/10.1016/j.arcmed.2020.05.016
Jahanshahlu L, Rezaei N (2020b) Monoclonal antibody as a potential anti-COVID-19. Biomed Pharmacother 129:110337. https://doi.org/10.1016/j.biopha.2020.110337
Jazieh AR, Al Hadab A, Al Olayan A, AlHejazi A, Al Safi F, Al Qarni A, Farooqui F, Al Mutairi N, Alenazi TH (2020) Managing oncology services during a major coronavirus outbreak: lessons from the Saudi Arabia experience. JCO Glob Oncol (6):518–524. https://doi.org/10.1200/GO.20.00063
Johns Hopkins University (2020) Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https://coronavirus.jhu.edu/map.html. Accessed 7 Apr 2020
Jordan RE, Adab P, Cheng KK (2020) Covid-19: risk factors for severe disease and death. BMJ 368:m1198. https://doi.org/10.1136/bmj.m1198
Kafieh R, Arian R, Saeedizadeh N, Minaee S, Yadav SK, Vaezi A, Rezaei N, Javanmard SH (2020) COVID-19 in Iran: A Deeper Look Into The Future. medRxiv
Kennedy JL, Turner RB, Braciale T, Heymann PW, Borish L (2012) Pathogenesis of rhinovirus infection. Curr Opin Virol 2(3):287–293. https://doi.org/10.1016/j.coviro.2012.03.008
Kim YJ, Boeckh M, Englund JA (2007) Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med 28(2):222–242. https://doi.org/10.1055/s-2007-976494
Kim YJ, Guthrie KA, Waghmare A, Walsh EE, Falsey AR, Kuypers J, Cent A, Englund JA, Boeckh M (2014) Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease. J Infect Dis 209(8):1195–1204. https://doi.org/10.1093/infdis/jit832
Kim YJ, Lee ES, Lee YS (2019) High mortality from viral pneumonia in patients with cancer. Infect Dis (Lond) 51(7):502–509. https://doi.org/10.1080/23744235.2019.1592217
Kuchar E, Miskiewicz K, Nitsch-Osuch A, Szenborn L (2015) Pathophysiology of clinical symptoms in acute viral respiratory tract infections. Adv Exp Med Biol 857:25–38. https://doi.org/10.1007/5584_2015_110
Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI (2020) A war on two fronts: Cancer Care in the Time of COVID-19. Ann Intern Med 172:756. https://doi.org/10.7326/M20-1133
Lambertini M, Toss A, Passaro A, Criscitiello C, Cremolini C, Cardone C, Loupakis F, Viscardi G, Meattini I, Dieci MV, Ferrara R, Giusti R, Maio MD (2020) Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective. ESMO Open 5(2). https://doi.org/10.1136/esmoopen-2020-000759
Lee JLC, Leong LP, Lim SL (2016) Nutrition intervention approaches to reduce malnutrition in oncology patients: a systematic review. Support Care Cancer 24(1):469–480. https://doi.org/10.1007/s00520-015-2958-4
Li T, Zhang Y, Gong C, Wang J, Liu B, Shi L, Duan J (2020) Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China. Eur J Clin Nutr 74:871. https://doi.org/10.1038/s41430-020-0642-3
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337. https://doi.org/10.1016/S1470-2045(20)30096-6
Lotfi M, Hamblin MR, Rezaei N (2020) COVID-19: transmission, prevention, and potential therapeutic opportunities. Clinica chimica acta 508:254–266. https://doi.org/10.1016/j.cca.2020.05.044
Lotfi M, Rezaei N (2020) SARS-CoV-2: a comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol 92:1864. https://doi.org/10.1002/jmv.26123
Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N (2020) The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19. Life Sci 258:118185. https://doi.org/10.1016/j.lfs.2020.118185
Mirbeyk M, Rezaei N (2020) The impact of COVID-19 on pregnancy and neonatal health: a systematic review
Mizumoto K, Kagaya K, Zarebski A, Chowell G (2020) Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the diamond princess cruise ship, Yokohama, Japan, 2020. Euro Surveill 25(10). https://doi.org/10.2807/1560-7917.ES.2020.25.10.2000180
Moazzami B, Razavi-Khorasani N, Dooghaie Moghadam A, Farokhi E, Rezaei N (2020) COVID-19 and telemedicine: immediate action required for maintaining healthcare providers well-being. J Clin Virol 126:104345. https://doi.org/10.1016/j.jcv.2020.104345
Mohamed K, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, Makka SA, Joya M, Makuku R, Islam MS, Radwan N, Rahmah L, Goda R, Abarikwu SO, Shaw M, Zoghi S, Irtsyan S, Ling I, Cseprekal O, Faten AB, Hazar Sayar E, Soloukey C, Grancini G, Rezaei N (2020a) Borderless collaboration is needed for COVID-19-a disease that knows no borders. Infect Control Hosp Epidemiol 41:1–2. https://doi.org/10.1017/ice.2020.162
Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N (2020b) Computational drug discovery and repurposing for the treatment of Covid-19: a systematic review. Available at SSRN 3583748
Momtazmanesh S, Ochs HD, Uddin LQ, Perc M, Routes JM, Vieira DN, Al-Herz W, Baris S, Prando C, Rosivall L, Abdul Latiff AH, Ulrichs T, Roudenok V, Aldave Becerra JC, Salunke DB, Goudouris E, Condino-Neto A, Stashchak A, Kryvenko O, Stashchak M, Bondarenko A, Rezaei N (2020) All together to fight COVID-19. Am J Trop Med Hyg 102(6):1181–1183. https://doi.org/10.4269/ajtmh.20-0281
Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA Jr, Martinez JA, Biamonte JD, Abdollahi M, Torres PJ, Nieto JJ, Ogino S, Seymour JF, Abraham A, Cauda V, Gupta S, Ramakrishna S, Sellke FW, Sorooshian A, Wallace Hayes A, Martinez-Urbistondo M, Gupta M, Azadbakht L, Esmaillzadeh A, Kelishadi R, Esteghamati A, Emam-Djomeh Z, Majdzadeh R, Palit P, Badali H, Rao I, Saboury AA, Jagan Mohan Rao L, Ahmadieh H, Montazeri A, Fadini GP, Pauly D, Thomas S, Moosavi-Movahed AA, Aghamohammadi A, Behmanesh M, Rahimi-Movaghar V, Ghavami S, Mehran R, Uddin LQ, Von Herrath M, Mobasher B, Rezaei N (2020) The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med 18(1):205. https://doi.org/10.1186/s12967-020-02364-2
Mukherjee RK, Back MF, Lu JJ, Shakespeare TP, Wynne CJ (2003) Hiding in the bunker: challenges for a radiation oncology department operating in the severe acute respiratory syndrome outbreak. Australas Radiol 47(2):143–145. https://doi.org/10.1046/j.0004-8461.2003.01165.x
Nasab MG, Saghazadeh A, Rezaei N (2020) SARS-CoV-2-a tough opponent for the immune system. Arch Med Res 51:589. https://doi.org/10.1016/j.arcmed.2020.05.020
Ngoi N, Lim J, Ow S, Jen WY, Lee M, Teo W, Ho J, Sundar R, Tung ML, Lee YM, Ngo E, Lim SW, Ong J, Lim F, Bonney G, Vellayappan B, Ho F, Tey J, Chan N, de Mel S, Poon M, Lee SY, Koh LP, Liu TC, Tan LK, Wong A, Wong A, Lim SE, Yeoh A, Wong JE, Tan D, Goh BC, Chng WJ, Soo R, Chee CE, Chee YL, Lee SC, Jeyasekharan AD, National University Cancer Institute S (2020) A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore. Ann Oncol doi:https://doi.org/10.1016/j.annonc.2020.03.306, 31, 840
Nishiura H, Kobayashi T, Suzuki A, Jung SM, Hayashi K, Kinoshita R, Yang Y, Yuan B, Akhmetzhanov AR, Linton NM, Miyama T (2020) Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis 94:154. https://doi.org/10.1016/j.ijid.2020.03.020
Norman K, Stobaus N, Smoliner C, Zocher D, Scheufele R, Valentini L, Lochs H, Pirlich M (2010) Determinants of hand grip strength, knee extension strength and functional status in cancer patients. Clin Nutr 29(5):586–591. https://doi.org/10.1016/j.clnu.2010.02.007
Oh WK (2020) COVID-19 infection in Cancer patients: early observations and unanswered questions. Ann Oncol 31:838. https://doi.org/10.1016/j.annonc.2020.03.297
Pashaei M, Rezaei N (2020) Immunotherapy for SARS-CoV-2: potential opportunities. Expert Opin Biol Ther 20:1–5. https://doi.org/10.1080/14712598.2020.1807933
Pino L, Perez C, Cardona A, Triana I (2020) Cancer Center recommendations to mitigate COVID-19 impact in patients with Cancer: low-resource settings version. JCO Glob Oncol (6):569–570. https://doi.org/10.1200/GO.20.00093
Pollyea DA, Amaya M, Strati P, Konopleva MY (2019) Venetoclax for AML: changing the treatment paradigm. Blood Adv 3(24):4326–4335. https://doi.org/10.1182/bloodadvances.2019000937
Pourahmad R, Moazzami B, Rezaei N (2020) Efficacy of Plasmapheresis and immunoglobulin replacement therapy (IVIG) on patients with COVID-19. SN Comprehensive Clin Med:1–5
Rabiee N, Rabiee M, Bagherzadeh M, Rezaei N (2020) COVID-19 and picotechnology: potential opportunities. Med Hypotheses 144:109917. https://doi.org/10.1016/j.mehy.2020.109917
Rezaei N (2020a) COVID-19 affects healthy pediatricians more than pediatric patients. Infect Control Hosp Epidemiol 1:1106. https://doi.org/10.1017/ice.2020.139
Rezaei N (2020b) COVID-19 and medical biotechnology. Avicenna J Med Biotechnol 12(3):139
Rivera A, Ohri N, Thomas E, Miller R, Knoll MA (2020) The impact of COVID-19 on radiation oncology clinics and cancer patients in the U.S. Adv Radiat Oncol. doi:https://doi.org/10.1016/j.adro.2020.03.006
Rokni M, Hamblin MR, Rezaei N (2020) Cytokines and COVID-19: friends or foes? Hum Vaccin Immunother:1–3
Rothan HA, Byrareddy SN (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun:102433. doi:https://doi.org/10.1016/j.jaut.2020.102433
Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, Van Hemelrijck M (2020) Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience 14:1022. https://doi.org/10.3332/ecancer.2020.1022
Rzymski P, Nowicki M, Mullin GE, Abraham A, Rodríguez-Román E, Petzold MB, Bendau A, Sahu KK, Ather A, Naviaux A-F (2020) Quantity does not equal quality: scientific principles cannot be sacrificed. Int Immunopharmacol 86:106711
Saghazadeh A, Rezaei N (2020a) Immune-epidemiological parameters of the novel coronavirus - a perspective. Expert Rev Clin Immunol 16(5):465–470. https://doi.org/10.1080/1744666x.2020.1750954
Saghazadeh A, Rezaei N (2020b) Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol 84:106560. https://doi.org/10.1016/j.intimp.2020.106560
Sahu KK, **dal V, Siddiqui AD (2020a) Managing COVID-19 in patients with Cancer: a double blow for oncologists. JCO Oncol Pract 16(5):223–225. https://doi.org/10.1200/op.20.00167
Sahu KK, Siddiqui AD, Rezaei N, Cerny J (2020b) Challenges for management of immune thrombocytopenia during COVID-19 pandemic. J Med Virol 92:2277. https://doi.org/10.1002/jmv.26251
Salako O, Okunade K, Allsop M, Habeebu M, Toye M, Oluyede G, Fagbenro G, Salako B (2020) Upheaval in cancer care during the COVID-19 outbreak. Ecancermedicalscience 14:ed97. https://doi.org/10.3332/ecancer.2020.ed97
Saleki K, Banazadeh M, Saghazadeh A, Rezaei N (2020) The involvement of the central nervous system in patients with COVID-19. Rev Neurosci 31(4):453–456. https://doi.org/10.1515/revneuro-2020-0026
Schrag D, Hershman DL, Basch E (2020) Oncology practice during the COVID-19 pandemic. JAMA 323:2005. https://doi.org/10.1001/jama.2020.6236
Shamshirian D, Rezaei N (2020) Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis
Shankar A, Saini D, Roy S, Mosavi Jarrahi A, Chakraborty A, Bharti SJ, Taghizadeh-Hesary F (2020) Cancer care delivery challenges amidst coronavirus disease - 19 (COVID-19) outbreak: specific precautions for Cancer patients and Cancer care providers to prevent spread. Asian Pac J Cancer Prev 21(3):569–573. https://doi.org/10.31557/APJCP.2020.21.3.569
Sharifkashani S, Bafrani MA, Khaboushan AS, Pirzadeh M, Kheirandish A, Yavarpour Bali H, Hessami A, Saghazadeh A, Rezaei N (2020) Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: potential therapeutic targeting. Eur J Pharmacol 884:173455. https://doi.org/10.1016/j.ejphar.2020.173455
Shereen NG, Salman D (2019) Delivering chemotherapy at home: how much do we know? Br J Community Nurs 24(10):482–484. https://doi.org/10.12968/bjcn.2019.24.10.482
Simcock R, Thomas TV, Estes C, Filippi AR, Katz MA, Pereira IJ, Saeed H (2020) COVID-19: global radiation oncology's targeted response for pandemic preparedness. Clin Transl Radiat Oncol 22:55–68. https://doi.org/10.1016/j.ctro.2020.03.009
Spicer J, Chamberlain C, Papa S (2020) Provision of cancer care during the COVID-19 pandemic. Nat Rev Clin Oncol 17:329. https://doi.org/10.1038/s41571-020-0370-6
Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P (2020) COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 20(4):400–402. https://doi.org/10.1016/S1473-3099(20)30132-8
The Cancer Letter (2020) What to expect: Oncology’s response to coronavirus in Italy “It’s like being in a war”. https://cancerletter.com/articles/20200311_1/. Accessed 9 Apr 2020
The Lancet O (2020) COVID-19: global consequences for oncology. Lancet Oncol 21(4):467. https://doi.org/10.1016/S1470-2045(20)30175-3
U.S. Food & Drug Administration (2020a) Coronavirus (COVID-19) Supply Chain Update. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-supply-chain-update?utm_campaign=022720_statement_coronavirus%20%28covid-19%29%20supply%20chain%20update&utm_medium=email&utm_source=eloqua. Accessed 9 Apr 2020
U.S. Food & Drug Administration (2020b) FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency. https://www.fda.gov/media/136238/download. Accessed 18 Apr 2020
Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL, McCreery B, Jagels B, Crane A, Byrd DR, Pergam SA, Davidson NE, Liu C, Stewart FM (2020) Managing Cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Cancer Netw 18:1–4. https://doi.org/10.6004/jnccn.2020.7560
Van Cutsem E, Arends J (2005) The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9(Suppl 2):S51–S63. https://doi.org/10.1016/j.ejon.2005.09.007
Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, Cuomo-Dannenburg G, Thompson H, Walker PGT, Fu H, Dighe A, Griffin JT, Baguelin M, Bhatia S, Boonyasiri A, Cori A, Cucunuba Z, FitzJohn R, Gaythorpe K, Green W, Hamlet A, Hinsley W, Laydon D, Nedjati-Gilani G, Riley S, van Elsland S, Volz E, Wang H, Wang Y, ** X, Donnelly CA, Ghani AC, Ferguson NM (2020) Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis doi:https://doi.org/10.1016/S1473-3099(20)30243-7, 20, 669
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, **ang H, Cheng Z, **ong Y, Zhao Y, Li Y, Wang X, Peng Z (2020a) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323:1061. https://doi.org/10.1001/jama.2020.1585
Wang Z, Wang J, He J (2020b) Active and effective measures for the Care of Patients with Cancer during the COVID-19 spread in China. JAMA Oncol 6:631. https://doi.org/10.1001/jamaoncol.2020.1198
Wat D (2004) The common cold: a review of the literature. Eur J Intern Med 15(2):79–88. https://doi.org/10.1016/j.ejim.2004.01.006
Wei W, Jiang H, Chen W, Zhou Y, Guo S, Zhong G, Zhou H, Wang S, Zhang H, Jiang W, Liu ZG (2020) How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19? Radiother Oncol 147:100–102. https://doi.org/10.1016/j.radonc.2020.03.016
World Health Organization (2020) Rolling updates on coronavirus disease (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen. Accessed 7 Apr 2020
Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323:1239. https://doi.org/10.1001/jama.2020.2648
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, **a P, Dong J, Zhao J, Wang FS (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8(4):420–422. https://doi.org/10.1016/S2213-2600(20)30076-X
Yang G, Zhang H, Yang Y (2020) Challenges and countermeasures of integrative Cancer therapy in the epidemic of COVID-19. Integr Cancer Ther 19:1534735420912811. https://doi.org/10.1177/1534735420912811
Yazdanpanah F, Hamblin MR, Rezaei N (2020a) The immune system and COVID-19: friend or foe? Life Sci 256:117900. https://doi.org/10.1016/j.lfs.2020.117900
Yazdanpanah N, Saghazadeh A, Rezaei N (2020b) Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev Neurosci 31:691. https://doi.org/10.1515/revneuro-2020-0039
You B, Ravaud A, Canivet A, Ganem G, Giraud P, Guimbaud R, Kaluzinski L, Krakowski I, Mayeur D, Grellety T, Lotz JP (2020) The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol 21:619. https://doi.org/10.1016/S1470-2045(20)30204-7
Yousefzadegan S, Rezaei N (2020) Case report: death due to COVID-19 in three brothers. Am J Trop Med Hyg 102(6):1203–1204. https://doi.org/10.4269/ajtmh.20-0240
Yu J, Ouyang W, Chua MLK, **e C (2020) SARS-CoV-2 transmission in patients with Cancer at a tertiary Care Hospital in Wuhan, China. JAMA Oncol 6:1108. https://doi.org/10.1001/jamaoncol.2020.0980
Zhang L, Zhu F, **e L, Wang C, Wang J, Chen R, Jia P, Guan HQ, Peng L, Chen Y, Peng P, Zhang P, Chu Q, Shen Q, Wang Y, Xu SY, Zhao JP, Zhou M (2020) Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan. China Ann Oncol 31:894. https://doi.org/10.1016/j.annonc.2020.03.296
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, **ang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nowroozi, A. et al. (2021). COVID-19 in Patients with Cancer. In: Rezaei, N. (eds) Coronavirus Disease - COVID-19. Advances in Experimental Medicine and Biology, vol 1318. Springer, Cham. https://doi.org/10.1007/978-3-030-63761-3_18
Download citation
DOI: https://doi.org/10.1007/978-3-030-63761-3_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-63760-6
Online ISBN: 978-3-030-63761-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)